InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.250
+0.040 (1.81%)
At close: Aug 13, 2025, 4:00 PM
2.260
+0.010 (0.44%)
Pre-market: Aug 14, 2025, 9:01 AM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,538
Profits / Employee
-$639,346
Market Cap
2.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INM News
- 17 days ago - InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - Newsfile Corp
- 6 weeks ago - InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Newsfile Corp
- 7 weeks ago - InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 7 weeks ago - InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study - Newsfile Corp
- 2 months ago - InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA - Newsfile Corp
- 3 months ago - InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 6 months ago - InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 6 months ago - InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp